Back to Search
Start Over
Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV–vis imaging
- Source :
- Journal of Pharmaceutical and Biomedical Analysis. 150:95-106
- Publication Year :
- 2018
- Publisher :
- Elsevier BV, 2018.
-
Abstract
- For poly (lactide-co-glycolide acid) (PLGA)-based in situ forming implants, the rate of implant formation plays an important role in determining the overall drug release kinetics. Currently, in vitro techniques capable of characterizing the processes of drug release and implant formation at the same time are not available. A hydrogel-based in vitro experimental setup was recently developed requiring only microliter of formulation and forming a closed system potentially suitable for interfacing with various spectroscopic techniques. The aim of the present proof-of-concept study was to investigate the feasibility of concomitant UV imaging, Vis imaging and light microscopy for detailed characterization of the behavior of in situ forming PLGA implants in the hydrogel matrix mimicking the subcutis. The model compounds, piroxicam and α-lactalbumin were added to PLGA-1-methyl-2-pyrrolidinone and PLGA-triacetin solutions. Upon bringing the PLGA-solvent-compound pre-formulation in contact with the hydrogel, Vis imaging and light microscopy were applied to visualize the depot formation and UV imaging was used to quantify drug transport in the hydrogel. As compared to piroxicam, the α-lactalbumin invoked an acceleration of phase separation and an increase of implant size. α-Lactalbumin was released faster from the PLGA-1-methyl-2-pyrrolidinone system than the PLGA-triacetin system opposite to the piroxicam release pattern. A linear relationship between the rate of implant formation and initial compound release within the first 4h was established for the PLGA-NMP systems. This implies that phase separation may be one of the controlling factors in drug release. The rate of implant formation may be an important parameter for predicting and tailoring drug release. The approach combining UV imaging, Vis imaging and light microscopy may facilitate understanding of release processes and holds potential for becoming a useful tool in formulation development of in situ forming implants.
- Subjects :
- In situ
Chemistry, Pharmaceutical
Hydrogel matrix
Clinical Biochemistry
Pharmaceutical Science
macromolecular substances
02 engineering and technology
Piroxicam
030226 pharmacology & pharmacy
Analytical Chemistry
03 medical and health sciences
chemistry.chemical_compound
Drug Delivery Systems
Subcutaneous Tissue
0302 clinical medicine
Ultraviolet visible spectroscopy
Polylactic Acid-Polyglycolic Acid Copolymer
Drug Discovery
Microscopy
medicine
Lactic Acid
Triacetin
Spectroscopy
Drug Implants
Drug Carriers
Spectrum Analysis
technology, industry, and agriculture
Hydrogels
021001 nanoscience & nanotechnology
Pyrrolidinones
Drug Liberation
PLGA
chemistry
Lactalbumin
Drug release
Spectrophotometry, Ultraviolet
Implant
0210 nano-technology
Polyglycolic Acid
medicine.drug
Biomedical engineering
Subjects
Details
- ISSN :
- 07317085
- Volume :
- 150
- Database :
- OpenAIRE
- Journal :
- Journal of Pharmaceutical and Biomedical Analysis
- Accession number :
- edsair.doi.dedup.....060586d13151cd8a4966cbc5cf19b8e7
- Full Text :
- https://doi.org/10.1016/j.jpba.2017.11.065